MAIA Biotechnology, Inc. (MAIA) Raises $695K in Private Placement to Advance Cancer Trial
MAIA Biotechnology, Inc. (NYSE:MAIA), a clinical-stage biopharmaceutical company, has announced a private placement agreement to raise approximately $695,000.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Marshall Wace LLP Paul Marshall And Ian Wace | 110,467 | $170,119 | +584% | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.98 | 10,000 | $9,785.00 | 399,483 | 2025-11-25 | Filing | |
| $0.97 | 10,500 | $10,144.05 | 831,421 | 2025-11-25 | Filing | |
| $0.98 | 15,000 | $14,700.00 | 1,349,289 | 2025-11-25 | Filing | |
| $0.99 | 10,000 | $9,900.00 | 1,334,289 | 2025-11-24 | Filing | |
| $0.99 | 10,000 | $9,891.00 | 820,921 | 2025-11-24 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,103,145 | $1,698,844 | 0% | |
| 2. | 574,898 | $712,874 | 0.16% | |
| 3. | 271,056 | $417,526 | 0% | |
| 4. | 104,857 | $161,479 | 0% | |
| 5. | 75,550 | $116,347 | 0% |